Clinical Trial Update: Neural Circuit Effects of Ketamine in Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial studying the neural circuit effects of ketamine in major depressive disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Major Depressive Disorder | Phase 4 | Status: RECRUITING